Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

President’s Request Boosts Food Safety Budget, Proposes Separate Agency

This article was originally published in The Tan Sheet

Executive Summary

In the White House budget document, FDA requests a $4.9 billion appropriation for fiscal 2016, up about $425 million from its budget for fiscal 2015. The $1.45 billion requested for food safety includes $109.4 million for implementing regulations developed over the past three years under FSMA

You may also be interested in...



DeLauro, Durbin Reheat Proposal For Separate Food Safety Agency

Sen. Richard Durbin and Rep. Rosa DeLauro introduce legislation to create a single, independent food safety agency from current oversight “split up among 15 different agencies.” Trade group executives say it is likely the 2015 bill will have the same fate as previous versions – passing neither the House nor the Senate.

E-Cigarettes Spark Evolution Of FDA’s Nicotine-Containing Medical Product Regulation

FDA’s tobacco, drug and medical device centers are discussing “some sort of jurisdictional policy” to “determine how to evolve the regulation of therapeutic nicotine products,” including OTC drugs, says tobacco program head Mitch Zeller.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS107489

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel